Slow-acting cornstarch supplement for Hypoglycemia
Phase-Based Progress Estimates
Effectiveness
Safety
UB MD Pediatrics Division of Pediatric Endocrinology, Buffalo, NY
Hypoglycemia+3 More
maltodextrin - DietarySupplementEligibility
< 18
All Sexes
What conditions do you have?
Select
Eligibility
< 18
All Sexes
What conditions do you have?
Select
Study Summary
In this within-subject cross-over study, the investigators hypothesize that corn-starch based supplements taken prior to exercise will decrease the risk of delayed hypoglycemia in adolescents with T1D, improve performance during exercise, and decrease glycemic variability during exercise.
Eligible Conditions
- Type 1 Diabetes Mellitus
- Hypoglycemia
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 3 Secondary · Reporting Duration: 12 hours after exercise challenge
Hour 12
Glycemic variability in the 12 hours following the exercise test
Number of hypoglycemic events 12 hours after completion of exercise challenge
Percent time above range, in range, and below range following exercise challenge
Percent time spent in hypoglycemia following exercise challenge
During exercise challenge
Glycemic variability during exercise challenge
Time to completion of distance bike challenge
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Slow-acting cornstarch supplement
1 of 2
Fast Acting Carbohydrate
1 of 2
Active Control
20 Total Participants · 2 Treatment Groups
Primary Treatment: Slow-acting cornstarch supplement · No Placebo Group · N/A
Slow-acting cornstarch supplement
DietarySupplement
ActiveComparator Group · 1 Intervention: super starch · Intervention Types: DietarySupplementFast Acting Carbohydrate
DietarySupplement
ActiveComparator Group · 1 Intervention: maltodextrin · Intervention Types: DietarySupplementTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 hours after exercise challenge
Closest Location: UB MD Pediatrics Division of Pediatric Endocrinology · Buffalo, NY
N/AFirst Recorded Clinical Trial
1 TrialsResearching Hypoglycemia
0 CompletedClinical Trials
Who is running the clinical trial?
State University of New York at BuffaloLead Sponsor
208 Previous Clinical Trials
44,220 Total Patients Enrolled
Lucy Mastrandrea, MD, PhDPrincipal InvestigatorState University of New York at Buffalo
Eligibility Criteria
Age < 18 · All Participants · 5 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:Your body mass index is greater than 10% or less than 95% of the normal range.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments